Tirzepatide
Tirzepatide (Mounjaro) is a once-weekly FDA-approved injectable medication developed for the treatment of type 2 diabetes. It is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. Tirzepatide works by increasing insulin release and reducing glucagon secretion, leading to improved blood glucose control.
In clinical trials, Tirzepatide has shown exciting results by lowering blood sugar levels, aiding in weight loss, and enhancing cardiovascular health. We recommend this treatment to help you reach your recommended BMI (body mass index).
Pricing guide
1st month/ $400
Initial evaluation
Labs workup
Meals Program
4 Tirzepatide injections starting dose / 1 weekly
Follow-up appointments remotely
2nd month/ $500
Reassessment
Labs workup
Meals Program
4 Tirzepatide injections increased dose / 1 weekly
Follow-up appointments remotely
3rd month/ $600
Reassessment
Labs workup
Meals Program
4 Tirzepatide injections increased dose / 1 weekly
Follow-up appointments remotely